Connect Biopharma Holdings Limited (CNTB) Discusses Phase 3 Atopic Dermatitis Study Results and Updates on Rademikibart Development Transcript By Pulse Sentinel · March 30, 2026 · 1 min read cntbsa transcripts Source: seekingalpha.com